You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Bulgaria's Sopharma cuts Jan-Apr sales 3% as domestic sales drop

Author Mario Tanev
Bulgaria's Sopharma cuts Jan-Apr sales 3% as domestic sales drop Sopharma/ All rights reserved

SOFIA (Bulgaria), May 7 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its sales revenue fell by an annual 3% in the January-April period of 2019, due to lower domestic sales. 

Sopharma's sales on the local market fell 15% year-on-year in the first four months of 2019, while sales abroad added 5%, the company said in a bourse filing.

In April alone, the company's sales decreased 7%. Exports lost 11%, while domestic sales were unchanged compared to April 2018.

The company did not disclose information about the volume of its sales or amount of sales revenue.

As at 12:20 CET on Tuesday, Sopharma shares traded unchanged at 3.35 levs ($1.92/1.71 euro) on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)

 

Compare